Showing 2,829 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

PrEP policies & guidelines

US: Only 891 in Free HIV-Prevention Drug Program Meant for 200,000

Editor's pick
Bloomberg Law
3 June 2020
PrEP policies & guidelines

Sex—and PrEP—During the Pandemic

Editor's pick
POZ
3 June 2020
PrEP policies & guidelines

England: PrEP to be phased into routine commissioning during 2020/2021

Editor's pick
Pharmaceutical Journal
29 May 2020
PrEP science

Matthew Hodson talks about PrEP and STIs Video

May 2020
Behaviour change interventions

Positive and motivational messages, not a focus on risk, needed for PrEP communications in South Africa

News
28 May 2020
Confidentiality, consent & medical ethics

Gilead Mailers Violated HIV Customers’ Privacy, Claims Lawsuit

Editor's pick
POZ
26 May 2020
Injectable & long-acting HIV treatment

Injectable antiretrovirals for HIV treatment or prevention: ambivalent views of potential users

News
26 May 2020
PrEP science

Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis (PrEP): Promising Results from HPTN 083

Editor's pick
TAG
21 May 2020
PrEP programmes & uptake

'I stopped PrEP and caught HIV': US researchers ask why

News
21 May 2020
PrEP programmes & uptake

CDC Issues New Guidance for Easier PrEP Access During COVID-19

Editor's pick
TheBodyPro
18 May 2020
Injectable & long-acting PrEP

Seventy per cent fewer HIV infections seen with PrEP injections, compared with pills, in gay/bi men and trans women

News
18 May 2020
PrEP science

Long-acting injectable drug prevents HIV infections

Editor's pick
Science
18 May 2020
PrEP science

Global HIV prevention study to stop early after ViiV Healthcare’s long-acting injectable formulation of cabotegravir dosed every two months shows higher efficacy than daily oral PrEP

Editor's pick
ViiV press release
18 May 2020
PrEP programmes & uptake

HIV preexposure prophylaxis underused by U.S. adolescents

Editor's pick
Reuters
12 May 2020
PrEP policies & guidelines

Adolescents on PrEP May Need More Hands-On Care

Editor's pick
POZ
6 May 2020
PrEP policies & guidelines

PrEP Advocates Call New Gilead Sciences Patent Suit Against HHS a 'Distraction'

Editor's pick
TheBody
5 May 2020
PrEP programmes & uptake

People Are Going off PrEP in the COVID-19 Era Because They’re Not Having Sex

Editor's pick
TheBody
28 April 2020
Pharmaceutical industry

Gilead ratchets up its Truvada patent fight with U.S. in new breach-of-contract lawsuit

Editor's pick
FiercePharma
28 April 2020
The search for an HIV prevention vaccine

HIV prevention trials paused during coronavirus crisis

News
22 April 2020
People & personal stories

My PrEP Story: Blaize (part 1)

Editor's pick
Prepster
17 April 2020
Improving HIV care

Coronavirus Elevates Telehealth for PrEP and Routine HIV Care

Editor's pick
TheBodyPro
15 April 2020
Hepatitis C transmission & prevention

Hepatitis C spreading through same networks and practices in HIV-positive and HIV-negative gay and bisexual men in England

News
15 April 2020
PrEP policies & guidelines

No more subsidised Truvada for Australians, but there are alternatives

Editor's pick
Star Observer
2 April 2020
Transmission & prevention

Top 10 HIV prevention stories from CROI 2020

News
2 April 2020